These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7783368)

  • 1. [Immunohistochemical study of proliferation index of astrocytomas classified by new histopathological grading].
    Takekawa Y; Sawada T; Sakurai I
    Rinsho Byori; 1995 May; 43(5):483-6. PubMed ID: 7783368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
    Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
    Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
    Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
    Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas.
    Haapasalo J; Mennander A; Helen P; Haapasalo H; Isola J
    J Clin Pathol; 2005 Mar; 58(3):263-8. PubMed ID: 15735157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of nuclear size and internuclear distance are important criteria for grading astrocytomas.
    Nafe R; Van de Nes J; Yan B; Schlote W
    Clin Neuropathol; 2006; 25(1):48-56. PubMed ID: 16465775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cell cycle regulator p27Kip1 is correlated with survival of patients with astrocytoma.
    Mizumatsu S; Tamiya T; Ono Y; Abe T; Matsumoto K; Furuta T; Ohmoto T
    Clin Cancer Res; 1999 Mar; 5(3):551-7. PubMed ID: 10100706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunohistochemical study of the expression of proliferating cell nuclear antigen in astrocytic gliomas of the cerebral hemispheres].
    Korshunov AG; Sycheva RV
    Arkh Patol; 1996; 58(2):32-7. PubMed ID: 8712938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas.
    Thotakura M; Tirumalasetti N; Krishna R
    J Cancer Res Ther; 2014; 10(3):641-5. PubMed ID: 25313753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between magnetic resonance diffusion weighted imaging and cell density in astrocytoma].
    Chen J; Xia J; Zhou YC; Xia LM; Zhu WZ; Zou ML; Feng DY; Wang CY
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):309-11. PubMed ID: 15996330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative activity and histopathological features in diffuse grade II astrocytomas.
    Lind-Landström T; Habberstad AH; Torp SH
    APMIS; 2012 Aug; 120(8):640-7. PubMed ID: 22779687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
    Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
    Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of frizzled 9 in astrocytomas.
    Zhang Z; Schittenhelm J; Guo K; Bühring HJ; Trautmann K; Meyermann R; Schluesener HJ
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):615-24. PubMed ID: 17083476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors.
    Erdamar S; Bagci P; Oz B; Dirican A
    J BUON; 2006; 11(2):213-6. PubMed ID: 17318973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of survival and the Daumas-Duport grading system for astrocytomas.
    Kim TS; Halliday AL; Hedley-Whyte ET; Convery K
    J Neurosurg; 1991 Jan; 74(1):27-37. PubMed ID: 1984503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RhoA protein expression correlates positively with degree of malignancy in astrocytomas.
    Yan B; Chour HH; Peh BK; Lim C; Salto-Tellez M
    Neurosci Lett; 2006 Oct; 407(2):124-6. PubMed ID: 16978776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
    Ono Y; Tamiya T; Ichikawa T; Kunishio K; Matsumoto K; Furuta T; Ohmoto T; Ueki K; Louis DN
    J Neuropathol Exp Neurol; 1996 Oct; 55(10):1026-31. PubMed ID: 8857999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.